PerkinElmer Supports PROXIDRUGS Consortium Aimed at Advancing Targeted Protein Degradation/PROTAC Drugs
Leading academic and industry cluster to help address 80% of disease-relevant human proteins currently undruggable WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a…